With this study we examined the activity of cefepime/zidebactam (WCK 5222) against consecutive reference laboratory submissions of Gram-damaging micro organism, taken as a sample of difficulty strains circulating in britain.isolates from all continents, Whilst the susceptibility rates for that comparator brokers were being commonly reduced in Europ